In vitro activity of micafungin against common and rare Candida species with the EUCAST, CLSI and E-test method: Intra- and inter-laboratory agreement [PublishAheadOfPrint]:
The emergence of resistant strains among common and rare Candida species necessitates continuous monitoring of in vitro susceptibility of those isolates. We therefore assessed the in vitro activity of micafungin against 1099 molecularly identified isolates belonging to 5 common and 20 rare Candida species with the EUCAST, CLSI and E-test methods assessing both the intra- and inter laboratory agreement between 2 centers. The median micafungin EUCAST MICs were from low to high C. albicans (0.004 mg/l), C. glabrata (0.016 mg/l), C. tropicalis (0.031 mg/l), C. krusei (0.125 mg/l) and C. parapsilosis (2 mg/l). Among rare Candida species, high MICs were found for C. guilliermondii, C. lipolytica, C. orthopsilosis, C. metapsilosis and C. fermentati. No resistant isolates were found with CLSI whereas 1-2% resistant rates were found with the EUCAST method. Overall, the EUCAST resulted in 1-2 dilutions higher MICs than the CLSI and the E-test methods. The intra- and inter-laboratory agreement between methods was >92% except the inter-laboratory agreement between EUCAST and CLSI (81%) where 17-31% of the differences were >2 two-fold dilutions for C. albicans, C. glabrata, C. tropicalis and other rare Candida species and <6% for C. parapsilosis and C. krusei. For the other inter-laboratory comparisons, EUCAST resulted in higher MICs than the Etest method for all species but <7% of these differences were >2 two-fold dilutions. Overall, the CLSI resulted in lower MICs than the E-test method with 11% of all isolates demonstrating >2 two-fold dilutions differences (6-20% for C. albicans, C. tropicalis and rare Candida species, <5% for C. glabrata, C. krusei and C. parapsilosis) and smaller differences found after 24h. Despite these differences, categorical agreement was excellent (>97%) with only 1-2% very major errors between EUCAST and the other two methods.
http://ift.tt/2aYUtVt
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
ALEXANDROS SFAKIANAKIS The evolving roles of computer-based technology and smartphone applications in facial plastic surgery Purpose of rev...
-
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182, alsfakia@gmail.com http://ift.tt/...
-
In honor of Ms. Marianne Clark, our Senior Account Executive here at Medical Legal Art who recently suffered a slip and fall on the ice wi...
-
Your subscribed feeds are not being updated automatically because this setting is turned off. Turn on automatic feed updates You...
-
Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1–Nrf2–ARE signaling pathway Publication date: 15 September 201...
-
Information for CME Credit—Mortality Risk Reductions for Replacing Sedentary Time With Physical Activities Publication date: May 2019 Source...
-
Abstract Recent research suggests that humans perceive quantity using a non-symbolic "number sense." This sense is then thought ...
-
COMMENTARY Autistic-undisciplined thinking in the practice of medical trichology p. 1 Ralph Michel Trueb, Hudson Dutra, Maria Fernanda Rei...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου